Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.50
+0.24 (4.56%)
Nov 21, 2024, 11:48 AM EST - Market open
Serina Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -7.4 | 5.27 | -2.68 | -1.26 |
| Depreciation & Amortization | 0.14 | 0.09 | 0.06 | 0.03 |
| Loss (Gain) From Sale of Assets | - | 0 | 0 | -0.03 |
| Loss (Gain) From Sale of Investments | - | - | 0.01 | 0.01 |
| Stock-Based Compensation | 1.61 | 0.02 | 0.01 | 0.08 |
| Other Operating Activities | -3.89 | -8.5 | 0.54 | -0.33 |
| Change in Accounts Receivable | 0.05 | - | 0 | 1.27 |
| Change in Accounts Payable | -0.81 | 0.39 | -0 | -0.37 |
| Change in Unearned Revenue | -0.12 | -0.15 | 0.15 | -1.61 |
| Change in Other Net Operating Assets | -2.33 | 0.4 | -0.16 | -0.05 |
| Operating Cash Flow | -12.43 | -2.48 | -2.08 | -2.25 |
| Capital Expenditures | -0.09 | -0.5 | -0.01 | -0.08 |
| Investment in Securities | - | - | 0.99 | 0.93 |
| Investing Cash Flow | -0.09 | -0.5 | 0.98 | 0.82 |
| Long-Term Debt Issued | - | 10.1 | 5 | - |
| Long-Term Debt Repaid | - | -0.05 | -3.69 | -0.01 |
| Net Debt Issued (Repaid) | 2.75 | 10.05 | 1.31 | -0.01 |
| Issuance of Common Stock | 5.08 | 0.01 | 0 | 1 |
| Financing Cash Flow | 8.17 | 10.07 | 1.31 | 1.08 |
| Net Cash Flow | -4.35 | 7.09 | 0.22 | -0.35 |
| Free Cash Flow | -12.51 | -2.98 | -2.09 | -2.34 |
| Free Cash Flow Margin | -396.46% | -94.53% | -352.55% | -67.41% |
| Free Cash Flow Per Share | -2.19 | -0.74 | -0.97 | -1.09 |
| Cash Interest Paid | - | - | 0.02 | 0 |
| Levered Free Cash Flow | -7.45 | -1.82 | -1.22 | - |
| Unlevered Free Cash Flow | -7.31 | -1.48 | -1.21 | - |
| Change in Net Working Capital | 0.32 | -0.87 | -0.15 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.